These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: No effect of genetic obesity and mazindol on imidazoline I2 binding sites in the brain of Zucker rats.
    Author: Miralles A, Ribas C, Olmos G, García-Sevilla JA.
    Journal: Eur J Pharmacol; 1993 Oct 26; 243(3):305-8. PubMed ID: 8276084.
    Abstract:
    The density and affinity states of imidazoline I2 binding sites as well as the density of alpha 2-adrenoceptors were quantitated in the brain of lean and obese Zucker rats. No significant differences were obtained between Zucker phenotypes for these receptors in the cerebral cortex and hypothalamus. Moreover, chronic treatment with the anorexic imidazoline derivative, mazindol, did not alter the density of brain imidazoline I2 binding sites. It is concluded that this genetic model of obesity is not associated with abnormal imidazoline I2 binding sites.
    [Abstract] [Full Text] [Related] [New Search]